Episode 392: ASCO GU 2025 - HIF Inhibition with Casdatifan in Refractory RCC

Toni Choueiri discusses the updated data from different cohorts of this novel HIF inhibitor.

Om Podcasten

Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is a Professor of Cancer Research and Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London